Vitality Watch

Dossier press news report 13-nov-2026
Press coverage of research or of a longevity trend

Liflex raises $5.25M Series A for anti-aging RNA therapies

Key claim: Biotechnology company Liflex secured $5.25 million in Series A funding to develop RNA therapies targeting aging.

Abstract

News coverage by Dealroom: “Liflex raises $5.25M Series A for anti-aging RNA therapies”. Headline and link only — this finding reports press coverage of a government action, not the primary record.

Why this matters

Biotechnology company Liflex secured $5.25 million in Series A funding to develop RNA therapies targeting aging.

Source

Link

Briefing card

Liflex raises $5.25M Series A for anti-aging RNA therapies
Stage: news report · press · 13-nov-2026

Biotechnology company Liflex secured $5.25 million in Series A funding to develop RNA therapies targeting aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://news.google.com/rss/articles/CBMilgFBVV95cUxPeHFxXy1uMXZCN0poUVAxNXJES1R6Q0VHT25qdEdZakFLNmtKRnhxNkExQ2IwTmtNSkI1ek11XzFrNVJVYVVCV2xHZVZXUEkzdm9PX3oyYVFVNERnMjlwTWpzQnNUMHhxYU1TMDY0VDVpd051Z3hjbmttdXVaY3RmREZnSU02TEpZTTF2TlBNel9aMXo3RWc?oc=5

build build 880 · 2bcef25 · 2026-11-18